EBITDA Analysis: Evaluating Xylem Inc. Against Booz Allen Hamilton Holding Corporation

Comparative EBITDA Growth: Xylem vs. Booz Allen

__timestampBooz Allen Hamilton Holding CorporationXylem Inc.
Wednesday, January 1, 2014531144000631000000
Thursday, January 1, 2015520410000588000000
Friday, January 1, 2016506120000637000000
Sunday, January 1, 2017561524000814000000
Monday, January 1, 2018577061000948000000
Tuesday, January 1, 2019663731000947000000
Wednesday, January 1, 2020745424000736000000
Friday, January 1, 2021834449000853000000
Saturday, January 1, 2022826865000755000000
Sunday, January 1, 20239581500001150000000
Monday, January 1, 20241199992000
Loading chart...

Infusing magic into the data realm

EBITDA Analysis: Xylem Inc. vs. Booz Allen Hamilton

In the ever-evolving landscape of corporate finance, EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) serves as a crucial metric for evaluating a company's operational performance. This analysis delves into the EBITDA trends of Xylem Inc. and Booz Allen Hamilton Holding Corporation from 2014 to 2023.

Over the past decade, Booz Allen Hamilton has demonstrated a steady growth trajectory, with its EBITDA increasing by approximately 126% from 2014 to 2023. In contrast, Xylem Inc. showcased a more volatile pattern, peaking in 2023 with a 82% increase from its 2014 figures. Notably, Xylem's EBITDA surpassed Booz Allen's in 2023, highlighting its robust financial health despite previous fluctuations.

This comparative analysis underscores the dynamic nature of these industries, offering valuable insights for investors and stakeholders seeking to understand the financial resilience of these corporations.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025